-
WHO IS MOST AT RISK OF UNRECOGNIZED DIABETES? A STUDY TO INFORM PHARMACIST ACTION
Mar 18, 2026, 21:38 PM -
OLD DATA, NEW TRICKS: ACCURACY AND EFFICIENCY GAINS FOR AI-DRIVEN SLR UPDATES
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Mar 18, 2026, 21:38 PM -
A METHODOLOGICAL REVIEW OF VALUATION STUDIES FOR THE EQ-5D-5L: EVOLVING PRACTICES AND LESSONS FROM THE EQ-5D-3L
Mar 18, 2026, 21:38 PM -
ARCHITECTURE OF RARE-DISEASE MODELS: STRUCTURAL CHOICES AND CLINICAL TRIAL ENDPOINT USE IN NICE HST EVALUATIONS
Mar 18, 2026, 21:38 PM -
USE OF MEDICATIONS WITHDRAWN FROM INTERNATIONAL MARKETS FOR SAFETY CONCERNS IN CHINA
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE USE AND COSTS ASSOCIATED WITH ENDOMETRIAL CANCER TREATMENT IN THE PUBLIC SETTING IN BRAZIL
Mar 18, 2026, 21:38 PM -
DRG-BASED DIFFUSION OF DAY SURGERY IN HUNGARY: CASE-GROUP AND PROVIDER VARIATION
Mar 18, 2026, 21:38 PM -
HEALTHCARE COST ASSOCIATED WITH CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME STAGES AMONG ADULTS IN THE UNITED STATES: ANALYSIS OF NATIONALLY REPRESENTATIVE DATA
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF HARTC 2.0 TRIAL: PREHOSPITAL ACS TRIAGE USING A MODIFIED HEART SCORE WITH POINT-OF-CARE HS-CTNI
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF ALPHA BLOCKERS VERSUS ALPHA INHIBITORS USING PATIENT-REPORTED OUTCOMES AMONG ADULT MEN DIAGNOSED WITH BPH IN THE USA USING MEPS DATA (2018-2023)
Mar 18, 2026, 21:38 PM -
AN AGENTIC AI FRAMEWORK INTEGRATING DATA-DRIVEN HYPOTHESIS GENERATION WITH TRADITIONAL VALIDATION FOR REAL-WORLD EVALUATION OF EMERGING THERAPIES
Mar 18, 2026, 21:38 PM -
EXPLORING THE RELATIONSHIP BETWEEN HEALTH-RELATED SOCIAL NEEDS AND CHRONIC DISEASE AMONG JEFFERSON HEALTH PATIENTS
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH ENABLE EARLY IDENTIFICATION OF PREMATURE MORTALITY RISK
Mar 18, 2026, 21:38 PM -
A HOLISTIC EVALUATION OF ADVERSE EFFECTS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) IN PROSTATE CANCER: AN ARTIFICIAL INTELLIGENCE ASSISTED TARGETED LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS, OUTCOMES, HCRU AND COSTS ASSOCIATED WITH PREVIOUSLY-TREATED EXTENSIVE-STAGE SCLC IN THE US FOLLOWING THE APPROVAL OF NEWER TREATMENT OPTIONS
Mar 18, 2026, 21:38 PM -
PHARMACOECONOMIC EVALUATION OF DIFFERENT GONADOTROPIN-RELEASING HORMONE ANALOGS IN THE TREATMENT OF PREMENOPAUSAL HORMONE RECEPTOR-POSITIVE BREAST CANCER IN CHINA
Mar 18, 2026, 21:38 PM -
REPORTING AI-ASSISTED METHODS IN PROSPERO-REGISTERED ONCOLOGY SLR PROTOCOLS: TRENDS AND GAPS
Mar 18, 2026, 21:38 PM -
DIGITAL CAREGIVER TRAINING FOR PROMOTING FUNCTIONAL INDEPENDENCE AND HEALTHY AGING
Mar 18, 2026, 21:38 PM -
PATIENT SUPPORT AND REAL-WORLD EVIDENCE GENERATION IN RARE DISEASE: A CASE STUDY IN HYPOPHOSPHATASIA
Mar 18, 2026, 21:38 PM
